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Renal  glomerular  disease  (membranous  glomerulonephritis)  is  the  main 
cause of death of NZB mice, especiMly of females, starting at about 10 months 
of age,  and is  almost certainly an immunologically induced  disorder  separate 
from,  but not  wholly unrelated  to,  the  autoimmune hemolytic disease which 
typifies  this  inbred  strain  (1-3).  The  renal  disorder  is  characterized  by:  an 
insidious onset beginning in some mice at about 4 months of age; a progressive, 
chronic,  usually fatal  course which  sometimes is  acutely  accelerated  and  as- 
sociated  with  positive lupus  erythematosus  (LE) 1 cell  tests  such  as  occur in 
human systemic LE and typify (NZB X  NZW) FI hybrid mice (1, 4); signifi- 
cant proteinuria noted commonly in the female in the later stage of the disease; 
and histopathological changes involving the capillary basement membrane and 
the mesangium of the glomeruli  (5, 6). 
NZB mice carry wild-type Gross leukemia virus apparently throughout life 
(9)  but,  unlike other G  (Gross)  antigen-positive inbred  strains  (7,  15),  NZB 
mice break tolerance to  G  antigens  and produce  G  natural  antibody in  later 
life  (9).  Proteinuria,  a  functional  manifestation  of  severe  renal  glomerular 
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disease,  becomes increasingly prevalent as  G soluble antigen, a  type-specific 
soluble antigen specified by wild-type Gross leukemia virus (7,  8),  undergoes 
immune elimination from the plasma  (9).  The cumulative mortality of NZB 
mice, mainly attributable to renal glomerular disease, increases in phase wittl 
the production of free G antibody (9). Murine leukemia virus (MuLV)-specified 
antigens and host  immunoglobulins, presumably antibodies,  are  localized in 
vivo in the glomerular lesions (9,  10). These findings implicate Gross leukemia 
virus in the etiology of glomerulonephritis of NZB mice and suggest that the 
host immune response to antigens of the G system (7, 15,  16), and hypersensi- 
tivity mediated by the deposition of G soluble antigen-antibody complexes in 
the  glomeruli, are  important contributory factors  in the  pathogenesis of  the 
renal disease (9). The present paper provides further supporting evidence for 
the hypersensitivity pathogenesis of the glomerulonephritis of NZB mice and 
also presents new and parallel findings which similarly implicate wild-type Gross 
leukemia virus and associated hypersensitivity  mechanisms in the pathogenesis 
of the accelerated renal disease (lupus glomerulonephritis) that typifies (NZB)< 
NZW) F1 hybrid mice. 
Methods and Materials 
Mice.--The following mice were used: NZB mice from our colony (10); NZB, NZW, and 
(NZB o  ~ )< NZW  9 ) F 1 hybrid mice produced from a breeding nucleus of NZB and NZW 
mice obtained from the Texas Inbred Mice Co., Houston, Tex., through the courtesy of Mr. 
Samuel M. Poiley, National Cancer Institute, National Institutes of Health, Bethesda, Md.; 
C57BL/6  and AKR mice from our colony and from Jackson Memorial Laboratory,  Bar 
Harbor, Maine; and CFW mice from Carworth Farms, New City, N. Y. The general methods 
of care and study were described elsewhere (9, 10). 
Urinalysls.--A fresh drop of urine was collected and tested for proteinuria by the use of 
reagent strips  (Albustix or Labstix, Ames Co., Elkhart,  Ind.) as previously described (10). 
Reactions of 2+ or greater on repeated tests at regular, including daily, intervals were graded 
as significant proteinuria. 
Kidney Homogenate.--The  kidneys of anesthesized mice were perfused in situ  with cold 
(4°C) Earle's balanced salt solution (EBSS) until  grossly free of blood. A block of kidney tissue 
was frozen at --70°C for immunofluorescence  study (as described subsequently) and the re- 
mainder was placed in an equal volume of EBSS, homogenized in a glass hand homogenizer, 
and centrifuged at 4°C and 1200 g, followed by collection of supernatant fluid (homogenate 
in Table I). 
Frozen sections of the perfused kidneys were stained by the direct immunofluorescence 
method for mouse (host) immunoglobulins, confirming the adequacy of the perfusion in re- 
moving unbound host immunoglobulins and the almost exclusive location of bound immuno- 
globulin in the renal glomerular lesions of NZB and (NZB X NZW) F1 hybrid mice (10, 11). 
Kidney Eluate.--The kidneys were perfused and homogenized  as previously described. The 
pH of the homogenate was lowered to 3.2 by the addition of 2.5 ~ citric acid, followed  by incu- 
bation at 4°C for 90 rain witb constant stirring, centrifugafion at 4°C and 1200 g, collection of 
the supernatant fluid, restoration of its pH to 7.4 by the addition of 2 N NaOH, further centrif- 
ugation, and collection of the supernatant fluid (acid-buffer eluate in Tables I and II). 
In order to obtain a purified eluate in sufficient amount for multiple tests, the acid-buffer 
eluate in Table III was prepared from the many times washed, saline-insoluble sediment of MELLORS~  SI-IIRAI~ AOKI,  ItUEBNER~  AND  KRAWCZYNSKI  115 
pooled kidney homogenate, as follows. Approximately 0.5 g of kidney tissue from each mouse 
was minced with scissors and washed three times  with six volumes of cold (4°C) EBSS, followed 
each time by centrifugation at 4°C and 1935 g for 15 rain. The washed tissue was frozen and 
stored overnight at --70°C. The tissue was thawed, pooled, placed in six volumes of EBSS, 
homogenized in a glass hand homogenizer, and centrifuged at 4°C and  12,100 g for 45  min. 
The supernatant fluid was removed. The remaining sediment was washed three times with pH 
7.6, 0.01 •  phosphate-buffered isotonic saline (PBS), followed each time by centrifugation at 
4°C and 3020 g for 15 mill. The washed sediment was suspended in several volumes (20 ml per 
g of starting tissue) of pH 3.2, 0.02 ~ citrate:phosphate-buffered  isotonic saline, and incubated 
at 37°C for 90 min with constant stirring. The suspension was then centrifuged at 4°C  and 
12,100 g for 30 mill. The supernatant fluid (240 ml) was removed, dialyzed against PBS at 4°C 
for 48 hr, and concentrated 4-, 8-, 16-, 32-, and 64-fold in a Diaffo Ultraflltration Cell (Model 
50,  Amicon Corp.,  Lexington,  Mass.).  The  eluate  was  shown by  immunoelectrophoretic 
analysis to contain mouse immunoglobulins but not other mouse serum proteins. Mouse 7S 
immunoglobulin concentration and antibody activity in the eluate were determined and com- 
pared with similar analyses of the serums of the donor mice. 
An acid-buffer eluate of the pooled kidneys of 14  (NZB  X  NZW) F1 hybrid mice, 10 fe- 
males and 4 males with an average age of 8 months (sI) 1.5), was made by the preparation of 
the saline-insoluble sediment of kidney homogenate and overnight treatment with deoxyribo- 
nuclease (obtained from Worthington Biochemical Corp., Freehold, N. J.), 0.2 mg per ml at 
pH 6.9 and 4°C, according to the procedure of Koffler et al.  (12), followed by elution with iso- 
tonic 0.05 M glycine-HCl buffer at pH 2.4. 
Immunodiffusion  and Immunoelectrophoresis Analysis.--Mouse  7S  ('yG)  immunoglobulin 
concentrations in the kidney eluate and sera were determined by quantitative radial immuno- 
diffusion analysis according to  the method of Mancini et  al.  (13).  Immunoelectrophoretic 
analysis of mouse serum proteins was performed by the micromethod of Scheidegger (14). 
Anti-Nuclear Antibody.--Cryostat  sections of normal guinea pig liver were air dried, fixed 
in 95% ethyl alcohol for 30 rain at room temperature, washed with PBS, and used as nuclear 
antigen for the detection of anti-nuclear antibody in mouse serums (or kidney eluate). The 
indirect method was used in the usual manner, as follows:  incubation of sections at  room 
temperature for 30 min with 0.1 ml of serum was followed by PBS wash and treatment with 
fluorescein-labeled  goat  antibody  to  mouse  immunoglobulins.  Reactions  were  graded  as 
definite positive (specific nuclear fluorescence)  or negative, and positive serums were titrated 
by doubling dilutions to an end point. Specificity  of the reaction was verified by the absorp- 
tion of the serum with calf thymus deoxyribonucleoprotein, and by the treatment of the sec- 
tions with deoxyribonuclease. Positive control serum was obtained from NZB mice, negative 
control serum from CFW mice. 
Anti-Erythrocyte Antibody.--A  6-8% suspension of ficin-treated  normal mouse erythrocytes 
obtained from CFW mice or Coombs' test-negative young NZB mice was prepared and used 
in  the usual manner for the serological  detection of incomplete warm  antibody to mouse 
erythrocytes. 2 drops of mouse serum (or kidney eluate) were mixed in a test tube with 1 drop 
of the erythrocyte suspension, incubated for 3 min at room temperature, centrifuged for 30 
see in  a  Sero-Fuge  (Clay-Adams, Inc.,  Parsippany, N.  J.),  and  observed for macroscopic 
agglutination. Tubes  showing no,  or  doubtful,  agglutination at  this  time were  incubated 
further at 37°C for 30 min, centrifuged, and reexamined. Reactions were graded as definite 
positive (macroscopic agglutination) or negative, and positive serums were titrated by dou- 
bling dilutions to an end point. Positive control serum was obtained from NZB mice, negative 
control serum from CFW mice. 
G (Gross) Typing Serum.--This serum was prepared by immunization of C57BL/6 female 
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glutination-inhibition (HI) polyoma antibody. A complete description of the G  typing sys- 
tem is given elsewhere (15). 
Determination of G Antibody.--The  serums, homogenates, and eluates were tested for G 
antibody by the indirect immunofluorescence method with suspensions of viable G-I- Ec~G2 
indicator cells.  Reactions were graded according to the proportion of cells showing charac- 
teristic membrane fluorescence:  <20%, negative; 21-50%, weak positive; 51-100~o,  strong 
positive. A complete description of this method is given elsewhere (16). 
Demonstration of G Soluble Antigen  (GSA  ) Adsorbed on  Viable Indicator Cells.--The  test 
was performed on plasma, homogenates, and eluates, and is based on the capacity of GSA 
to adsorb to cell membranes where it is demonstrable by immunofluorescence with G typing 
serum (7). Ascites leukemia EL4 cells served as the indicator cells; EL4 does not carry G or 
FMR cellular antigens (15). The plasma of AKR mice served as positive control. A detailed 
description of this method is given elsewhere (7). 
MuLV  CF Antigen.--The  complement-fixation (CF)  method  for  the  detection of  CF 
antigens with murine leukemia virus (MuLV) group and type speeificities  is described else- 
where (17, 18). The rat antisera used in the CF  test were transplanted lymphomas or sar- 
comas induced respectively by murine leukemia viruses or the Moloney strain of murine sar- 
coma virus  (19), and were selected for antibody specificity with respect to MuLV antigens 
and  for absence of nonspecific  reactions with extracts of normal tissues of various mouse 
strains. CF tests were made on 10% extracts of tissues at a starting dilution of 1:2 or 1:4, 
and CF-positive extracts were titrated at doubling dilutions to an end point. Positive 3+ 
and 4+ reactions in the absence of anticomplimentary effects and in the absence of positive 
reactions with negative control extracts were scored as positive. 
MuLV IF Antlgens.--The  indirect immunofluorescence (IF) method for the detection in 
unfixed frozen tissue sections of IF antigens with MuLV group and  G  type specificities  is 
described elsewhere (9). The rat antiserum used in the IF test was prepared in the laboratory 
of Dr. Lloyd Old by the method of Geering et al.  (20), and kindly provided by these authors 
for this study. This antiserum was obtained from (W/Fu X  BN) F1 rats bearing subcutane- 
ous transplants of the Gross virus-induced leukemia W/Fu  (C58NT)D.  The antiserum did 
not contain detectable anti-nuclear antibody by the indirect IF method, nor HI polyoma anti- 
body, and did not react in immunodiffusion tests with mouse serum proteins. The fluorescein- 
labeled goat antibody against rat T-globulins gave a single line of precipitation of rat T-glob- 
ulins in immunodiffusion tests with rat serum, and was thoroughly absorbed with lyophilized 
normal  mouse  serum  to  remove  cross-reacting antibody  against  mouse  T-globulins.  This 
absorbed reagent was negative in direct IF reactions with mouse kidneys, whether normal or 
glomerulonephritic. Negative control reactions in the indirect IF method included the use of 
normal (nonimmune) W/Fu rat serum and partial inhibition of (W/Fu X  BN)  F1 rat anti- 
serum by absorption with soluble extract of EoZG2 leukemia cells prepared by the method of 
Geering et al.  (20), or by absorption with the plasma of AKR mice carrying leukemia K36, 
whereas the plasma of C57BL mice failed to do so. The normal kidneys of C57BL mice served 
as additional negative controls. All mouse tissues were unfixed,  frozen at  -70°C, and sec- 
tioned at 1-2 #. Mouse immunoglobulins were located by the direct IF method with fluores- 
cein-labeled antibody against mouse T-globulins,  as previously described (10). 
Histopathology.--The autopsy procedures and  histological methods were  described else- 
where (10). 
Electron Microscopy.--The methods of procedure were described elsewhere (21). 
RESULTS 
NZB  Mice 
G Soluble Antigen (GSA).--Tests for GSA were performed on the plasma and 
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NZB mice 2-14 months of age (Table I). The results obtained on the kidneys 
of the individual mice are illustrated in Fig.  1. The mice were also tested for 
proteinuria. 
Significant proteinuria (2+ reaction or greater) occurred in NZB mice 10 and 
14 months of age and  slightly in  advance  of this,  in keeping with previous 
findings (9). GSA was detectable in the plasma at 10 and 14 months, although 
it is known to appear in NZB mice somewhat earlier (9). 
The  tests  for  GSA  were  negative  in  each  of  16  kidney homogenates.  In 
significant contrast, the tests for GSA were positive in 5 of 12 kidney eluates, 
with positive results occurring at 6-14 months. 
TABLE I 
G Soluble Antigen and  G Natural Antibody in Plasma and Serum and in Homogenate and 
Acid-Buffer Eluate of Perfused Kidneys of NZB Mice at Various Ages, 
with and without Proteinuria 
Proteinuria 
Age  No. positive/' 
No. tested 
G soluble antigen* 
(No. positive/No, tested) 
G natural antibody$ 
(No. positive/No, tested) 
Plasma  Homogenate  Eluate  Serum  Homogenate  Eluate 
Mont~ 
2-4  0/4  0/2  0/4  0/2  0/4  1/8 
6  0/4  0/2  0/2  1/2  0/4  0/2  3/4 
8  1/4  0/2  0/4  2/2  0/4  0/4  3/4 
10  6/6  3/3  0/4  1/3  0/6  0/4  5/6 
14  6/6  2/3  0/2  1/3  2/6  0/2  5/6 
Summation  0/16  5/12  0/12  17/28 
P  (chi-square test)  P  <  0.01  P  <  0.001 
* Indicator cells, EL4 cells. 
Indicator cells, E#G2 cells. 
GSA in the kidney eluate was shown to react with G antibody from several 
sources (Table II), including the individual serums of 4 NZB mice 11-15 months 
of age,  a  serum  pool obtained from retired breeder  C57BL/6 mice, and the 
G  typing serum C57BL/6 anti-AKR spontaneous leukemia K36.  As indicated, 
not only by the per cent of fluorescent indicator cells (Table II), but also by the 
intensity and magnitude of membrane fluorescence (Fig. 2), the serum of some 
NZB mice (for example, No. 4667) reacted more strongly with the antigen in 
kidney eluate than did the G typing serum. 
G Natural Antibody.--Tests for G  natural antibody were performed on the 
serum and on the homogenate and the acid-buffer eluate of the perfused kidneys 
of female NZB mice 2-14 months of age (Table I). The results obtained on the 
kidneys of the individual mice are shown in Fig. 1. 
Positive tests for G natural antibody in the serum were observed in some mice 
by 14 months of age, in keeping with previous findings (9). 118  LEUKEMIA  AND  MICE  GLOM~ERITLONEPHRITIS PATHOGENESIS 
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FIG. 1.  Tests for G soluble antigen  (triangles)  and  G natural antibody  (circles)  in homo- 
genates (open  symbols)  and acid-buffer eluates  (closed  symbols)  prepared  from the kidneys 
of NZB mice at various ages. Reactions are graded  by proportion  of  indicator  cells  show- 
ing  membrane  immunofluorescence:  negative  (620%) ; weak  positive  (21-50%);  strong 
positive (51-100%). 
TABLE  II 
Reactivity  of  G  Soluble  Antigen  in  Acid-Buffer  Eluate  of Kidneys  of  6  NZB  Mice  with 
Proteinuria  (Mean Age,  13.6 Months,  sD 0.9)  with G Antibody in Serums 
of NZB  and C57BL/6  Mice 
Fluores- 
G  soluble antigen Source  G  antibody  Source  cent 
ceils* 
Kidney eluate, NZB mice 
Plasma, AKR mouse 
11 month old  9  NZB mouse No. 5183 serum 
12  "  "  "  "  "  No. 5060  " 
14  "  "  "  "  "  No. 4667  " 
15  "  "  "  "  "  No. 5230  " 
Retired breeder C57BL/6 mouse serum pool 
C57BL/6 anti K36 mouse serum pool 
10 month old o  ~ NZB mouse No. 5311 serum 
% 
80 
55 
96 
37 
61 
86 
86 
57 
* EL4 cells, positive reaction, >20%. 
The tests  for G  natural  antibody  were negative in  12  kidney  homogenates. 
Contrasting  very significantly with  these results,  the tests  for G  natural  anti- 
body were positive in 17 of 28 kidney eluates. The first positive test for G natural 
antibody  in the kidney  eluate  was  observed  at  4  months  of age  (Fig.  1),  and 
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Autoantibodies.--Tests  for anti-nuclear antibody, anti-erythrocyte antibody, 
and G natural antibody were performed on the acid-buffer eluate prepared from 
the saline-insoluble sediment of the kidneys of NZB mice and on representative 
serums obtained at the same time from these mice. As described under Methods 
and Materials, the antibody tests on the eluate were made  on  samples taken 
FIG. 2.  GSA in NZB kidney eluate adsorbed to surface of EL4 indicator cells and reacted 
with NZB mouse serum No. 4667 (Left)  and with G typing serum C57BL/6 anti-AKR spon- 
taneous leukemia K36 (Middle);  EL4 cells alone, negative control (Right).  Membrane immuno- 
fluorescence, indirect method,  using  fluorescein-labeled goat  antibody to  mouse  immuno- 
globulins. X  500. 
during the concentration procedure. The  concentration of mouse  7S immuno- 
globulins (Ig)  in the eluate and the serums was also measured.  The  antibody 
titer in the serums was expressed as the reciprocal of the highest serum dilution 
giving a  positive end point. The arithmetic mean titer was calculated and nor- 
malized to a 7S Ig concentration of 10 mg/ml for the comparison of the antibody 
activities in the eluate and the serums. 
The  following results  were  obtained  (Tables  III  and  IV).  The  normalized 
titer of G  natural antibody in the kidney eluate was 25, in the serum,  12; the 120  LEUKEMIA  AND  MICE GLOMERULONEPHRITIS PATItOGENESIS 
ratio  (eluate/serum) was 2.1.  The normalized titer of antinuclear antibody in 
the kidney eluate was 25,  in  the serum 32;  the ratio  (eluate/serum)  was 0.8. 
The normalized titer of anti-erythrocyte antibody in the kidney eluate was 25, 
in  the serum 56;  the ratio  (eluate/serum)  was 0.5.  Thus,  of the three serum 
antibodies, all were detectable in the kidney eluate but only G natural antibody 
TABLE  III 
Antibody  Titers in Acid-Buffer  Eluate Prepared from Pooled Kidneys of 28 NZB Mice with 
Proteinuria  (Mean Age, 11.6 Month~, sI) 2.3), Contrasted with Serum Antibody  Titers* 
Antibody in eluate  Normal- 
ized anti- 
7s Ig conc. (mg/mI) and result  Normal- body titer 
ized  ratio 
Antibody  antibody  Eluate/ 
titer 
<0.2  0.2  0.4  0.8  3.0  (7S Ig  Serum*  (7S Ig  concn., Conen.,  10 
I0 mg/ml) mg/ml) 
G natural antibody+*  -(9%)  --(19~)  +(42~)  +(29%)  +(28%)  25  2.1 
Anti-nuclear antibody  --  --  +  +  +  25  0.8 
Antl-erythrocyte  antibody  --  --  +  +  +  25  0.5 
* Normalized serum antibody titers for mice in this experiment  are given in Table IV. 
:~ (%), % fluorescent  cells (Eo~G2 cells), positive reaction, >20%. 
TABLE  IV 
Antibody  Titers in Serums Obtained from 9 NZB Mice with Proteinuria 
(Mean Age, 11.1 Months, sD 1.5) 
Serum dilution  Antibody titer 
Antibody  Number  Number  of positive  tests  Arithme-  Normalized§ 
of tests  tic  7S Ig concn., 
1:8"  1:16"  1:32"  1:64  1:128  mean:~  10 mg/ml 
G natural antibody*  9  3  3  1  11  12 
Anti-nuclear antibody  9  2  4  2  1  30  32 
Antl-erythrocyte antibody  9  2  4  1  2  52  56 
* In the test for G natural antibody, serum dilutions were actually 1:7,  1:15,  and 1:30; 
two of nine serums were negative and graded 0. Indicator cells, Eo  ~ G2 cells. 
:~ Calculated from reciprocal of dilutions. 
§ Measured 7S Ig concn, was 9.4 mg/ml. 
was more concentrated in  the eluate  than in  the serum. However, it is  to be 
noted that if only the  G  antibody-positive serums in  Table IV were used,  the 
normalized titer of G  antibody in the serum would be 15 and the ratio (eluate/ 
serum) would be somewhat less, namely 1.7. 
(NZB  X  NZW)  F1 Hybrid Mice (and Parental Strains) 
MuLV  CF Antigens.--The  complement-fixation (CF)  test  for  murine  leu- 
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liver, and kidneys of 13 (NZB  >(NZW)  F: hybrid mice 6-13 months of age 
(Table V). All of the tissue extracts tested were CF antigen-positive at a dilu- 
tion of 1:8, and a large majority was positive at a dilution of 1:16. 
The test for MuLV  CF  antigens  was  performed  on  tissue  extracts of the 
spleen, liver, and kidneys of 7 NZW mice of 18 months of age. All of the ex- 
tracts tested were CF antigen-positive at a dilution of 1: 8, and a large majority 
was positive at a dilution of 1:16. 
Comparable positive results were obtained on extracts of the spleen, liver, 
and kidneys of NZB mice at 8 months, in keeping with previous findings (9). 
MuLV IF Antigens.--Unfixed  frozen sections of the perfused kidneys of 6 
(NZB)< NZW) F1 hybrid mice were studied by the indirect immunofluorescence 
(IF)  method, using a  broadly reactive rat antiserum  (see Methods and Ma- 
terials), for the location of murine leukemia virus IF antigens. The hybrid mice 
were females. One was 6 months, three were 7 months, and two were 8 months 
TABLE  V 
MuLV CF Antigens in Tissue Extracts of (NZB  X  NZW)  F: Hybrid, NZW, and NZB Mice 
Tissue extract (dilution) 
Mice  No.  Age  Spleen  Liver  Kidney 
1:8  I:16  1:8  1:16  1:8  1:16 
Months  No. antigen positive~No, tested 
(NZB X  NZW) F1  20  6-13  19/19  14/19  20/20  20/20  8/8  7/8 
NZW  7  18  6/6  5/6  7/7  7/7  7/7  6/7 
NZB  5  8  5/5  3/4  5/5  4/4  3/3  2/3 
of age, and all had highly significant (3+) proteinuria. MuLV IF antigens were 
located in the renal glomeruli in the four younger mice, almost exclusively in 
the wall of the peripheral capillary loops and in the mesangium of the glomeruli; 
in two of these mice, MuLV IF antigens were detectable in virtually all glo- 
meruli in the frozen sections (Fig. 3). The deposits of MuLV IF antigens were 
granular or homogeneous; their distribution within a glomerulus was segmental 
or diffuse. The negative controls in the indirect method for the detection of 
MuLV IF antigens included the use of normal rat serum (Fig. 4) and the study 
of frozen sections of the kidneys of normal C57BL/6 mice (Fig. 5). These con- 
trols  and  the  direct stain  gave negative  reactions.  The indirect reaction for 
MuLV IF antigens  (Fig. 6)  was partially inhibited by prior absorption of the 
rat antiserum with the plasma of AKR mice carrying the G+ AKR spontane- 
ous leukemia K36 (Fig. 7),  or with a soluble extract of ECG2 leukemia cells 
(Fig. 8). 
Autologous (host) immunoglobulins were bound to the glomeruli of (NZB X 
NZW)  FI mice (11), as shown by the parallel study of adjacent sections with 
fluorescent  antibody  against  mouse  immunoglobulins.  The  bound  immuno- FIG. 3.  Frozen section of perfused kidney of 7 month old female (NZB X  NZW) F1 hybrid 
mouse. MuLV IF antigens (white areas) located in the mesangium (left) and in the wall of the 
peripheral capillary loops (right) of two glomeruli. Indirect IF procedure using rat antiserum 
against  MuLV  IF  antigens followed  by  fluorescent  anti-rat  ")'-globulins,  neither of which 
reagents reacted with mouse serum proteins. (see Methods and Materials). X  418. 
FIG. 4.  Negative control for Fig. 3.  Frozen section of same kidney.  Indirect IF procedure 
using normal rat serum followed  by fluorescent anti-rat 3,-globulins. M 418. 
FIC.  5.  Negative control for  Fig.  3.  Frozen  section of perfused  kidney of  2  month  old 
C57BL/6 mouse. Indirect IF procedure using rat antiserum against MuLV IF antigens fol- 
lowed by fluorescent anti-rat "y-globulins.  X  418. 
122 FIc. 6.  Frozen section of perfused kidney of 7 month old female (NZB X  NZW) F1 hybrid 
mouse. MuLV IF antigens (white areas) located in the mesangium and the wall of the periph- 
eral capillary loops of  two  glomeruli.  Indirect  IF  procedure  using  rat  antiserum  against 
MuLV IF antigens followed by fluorescent anti-rat 3'-globulins. X  418. 
FIG. 7.  Frozen section of same kidney as in Fig. 6. Indirect IF procedure using rat antiserum 
against 1VIuLV IF antigens absorbed with the plasma of AKR mice carrying the G-k AKR 
spontaneous leukemia K36.  Glomerular immunofluorescence is decreased relative to Fig.  6. 
X  418. 
Fro. 8.  Frozen section of the same kidney as in Fig. 6. Indirect IF procedure using rat anti- 
serum  against MuLV  IF  antigens absorbed with soluble extract of  EcVG2  leukemia cells. 
Glomerular immunofluorescence is decreased relative to Fig. 6. 
123 FIG. 9.  Frozen section of perfused kidney of 7 month old female (NZB X  NZW) F1 hybrid 
mouse. Autologous bound immunoglobulins  located in the wail of the peripheral capillary loops 
and in the mesangium of the glomerulus. Direct IF procedure using fluorescent anti-mouse 
"y-globulins.  X  418. 
Fro.  10.  Frozen section of perfused kidney of  11  month old female NZB  mouse.  Autol- 
ogous bound immunoglobulins located mainly in the mesangium of  two  glomeruli.  Direct IF 
procedure using fluorescent anti-mouse 3,-globulins.  X  418. 
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globulins were located in the wall of the peripheral capillary loops and in the 
mesangium of the glomeruli (Fig. 9); their glomerular distribution was similar 
to but somewhat more widespread than the MuLV IF antigens. 
Frozen sections of the per[used kidneys of 6 NZB mice 2-10 months of age 
were similarly studied for MuLV  IF  antigens.  The reactions for MuLV  IF 
antigens were negative at 2-4 months, weakly positive in glomerular mesangial 
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FIO.  11.  Tests (% positive) /or GSA (O), G natural antibody  (O), and significant pro- 
teinuria (A) performed on (NZB X  NZW) Fi hybrid mice at various ages.  Horizontal bar at 
50% positive, age mean :t:SE. 
foci at 6-8 months,  and more strongly positive at 9-10 months.  Autologous 
(host)  immunoglobulins  were  bound  to  the  glomeruli  at  4-12  months,  in- 
creasing in amount with age (Fig. 10). These results on NZB mice corresponded 
to previous findings (9, 10). 
The reactions for MuLV IF antigens were weakly positive in some glomeruli 
in the per[used kidneys of a female AKR mouse 8 months of age. 
GSA.--81 tests for GSA were performed on the plasmas of 16 (NZB X  NZW) 
F1 hybrid mice equally divided as to sex and studied at 1-9 months of age. The 
results are shown in Figs. 11 and 12 and in Table VI. The first positive reactions 126  Lt~UI~IA  AND  MICE  GLOMERULONEPttRITIS  PATItOGENESIS 
for GSA in the hybrid mice occurred at 2 months; 50% of the reactions were 
positive at 3.3 -1- 0.6 months, and nearly 90% were positive at 6 months. Be- 
yond the  6th month,  GSA underwent elimination from the plasma;  positive 
reactions were reduced to 50% at 7.6 4- 0.3 months and continued to fall there- 
after. 
The first positive reactions for GSA in NZB mice occurred at 3 months, and 
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FIG. 12.  Tests for GSA (O) and G natural antibody (O) performed on (NZB X  NZW) F1 
hybrid mice at various ages. Reactions are graded by per cent of indicator cells showing mem- 
brane immunofluorescence: negative  (=< 20%) ; weak positive (21-50°-/o); strong positive (51- 
100%). 
the 50% response time for GSA production and elimination was 5.3 -4- 0.4 and 
13.3 -4- 0.6 months, respectively, as previously reported (9). This occurrence is 
significantly later than that observed in (NZB  X  NZW)  F1 hybrid mine. 
74 tests for GSA were performed on the plasmas of 10 NZW mice 1-11 months 
of age. The reactions were graded by the per cent of indicator ceils  showing 
membrane  immunofluorescence  (see  Methods  and  Materials)  as  follows: 
negative  ( _-< 20 %),  weak positive  (21-50 %),  and strong positive  (51-100 %). 
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and 40 negatives; 7-10 months, 12 weak positives and 7 negatives; 11 months, 
4 strong positives, 5 weak positives, and 5 negatives. Except for one early, weak 
positive reaction, GSA production in NZW mice was delayed in time and amount 
in comparison with NZB mice and (NZB X  NZW) F1 hybrid mice. 
G Natural Antibody.--21  tests for G natural antibody were performed on the 
serums of 10  (NZB)<  NZW)  F1 hybrid mice  equally divided  as to sex and 
studied  at 5-11  months of age. The results are shown in Figs.  11  and  12  and 
in Table VI. The first positive reactions for G natural antibody in the hybrid 
mice occurred at 5 months of age; 50% of reactions were positive at 5.8  ±  0.9 
months, and a large majority was positive thereafter. 
The first positive reactions for G natural antibody in NZB mice occurred at 
10 months,  and the 50% response time was 13.3  -4- 0.4 months,  as previously 
TABLE VI 
50% Response Time  (Tso) for  GSA  Production and Elimination and G Antibody Production 
in (NZB X  NZW) Fx Hybrid Mice 
Response  T~0*  sE  sD  N' 
Months  Months  Months 
GSA production  3.3  0.6  3.1  51 
G natural antibody  5.8  0.9  2.4  15 
GSA elimination  7.6  0.3  1.3  15 
* Estimated  by logarithmic-probit procedure and based upon N' determinations in the  /---- 
6.7-93.3% range of response. Standard error (SE) equals SD --  A/N'  . 
V  2 
reported  (9). This occurrence is significantly later than observed in  (NZB  X 
NZW) F1 hybrid mice. 
31  tests for G  natural  antibody were performed on the serums of 10 NZW 
mice 8-18 months of age. The results were as follows: 8-9 months, 14 negatives; 
11 months, 2 positives and 8 negatives; 18 months, 6 positives and 1  negative. 
The detectability of G  natural  antibody in NZW mice was substantially de- 
layed in  comparison with  (NZB  X  NZW)  F1  mice,  but  not  appreciably de- 
layed in comparison with NZB mice. 
Proteinuria.--46  tests for proteinuria were performed on 10 (NZB  XNZW) 
F1 hybrid mice of both sexes, and the mice were studied at 4-8 months of age. 
The  results  are  shown  in  Fig.  11  and  in  Table VII.  Significant  proteinuria 
(positive reactions of 2+  or greater) occurred in some of the hybrid mice at 5 
months of age and in 50% at 7.3 4- 0.6 months. 
Cumulative  Mortality.--Mortality  statistics  were  tabulated  at  monthly 
intervals on 40 (NZB  X  NZW) F1 hybrid mice equally divided as to sex. The 
results are shown in Table VII. 50% of the hybrid mice were dead at 8.0 4- 0.2 128  LEUI~EM~  AND  MICE  GLOMERULONEPI-IRITIS  PATHOGENESIS 
months. The major cause of death was renal glomerular disease (membranous 
and lupus glomerulonephritis) as verified by autopsy. 
DISCUSSION 
The present paper deals with  the pathogenesis of "spontaneous" glomeru- 
lonephritis of NZB and (NZB)  NZW) F1 hybrid mice as studied from an im- 
munological point of view, and as related to the antigens associated with wild- 
type Gross leukemia virus infection. 
This study revealed the presence of G (Gross) soluble antigen (GSA) and the 
early and selective concentration of G natural antibody in the kidneys of  NZB 
mice. These two reactants were apparently present in the kidneys as antigen- 
antibody complexes but not as free forms, for they were detected only in the 
eluates and never in the homogenates of kidneys. While the quantity of G anti- 
body detected in  the kidney eluate did not necessarily represent the precise 
TABLE VII 
50% Response Time (Tso)  for Significant Proteinuria and Cumulative Mortality in 
(NZB  X  NZW) F1 Hybrid Mice 
Response  Too*  SE  SD  N J 
Months  Months  Months 
Significant proteinuria  7.3  0.6  2.7  41 
Cumulative mortality  8.0  0.2  1.4  160 
* See footnote, Table VI. 
amount present,  owing to the possibility of antibody recombination with co- 
existing GSA in the eluate during the measurement, the quantity of G antibody 
actually measured in this study can be taken as an indication of the relative 
amount. G antibody was detectable in the kidney eluates of mice approximately 
4-6 months of age, whereas it first appeared in the sermn of NZB mice at about 
10 months of age (9). The detection of G antibody in the kidney eluates, even 
before the manifestation of proteinuria, is in accord with the fact that glomerular 
lesions and glomerular-bound immunoglobulins are demonstrable in NZB mice 
in advance of proteinuria (10). The interpretation of these findings is that  G 
antibody is produced by NZB mice at a young age and is combined with GSA 
to form antigen-antibody complexes which deposit in the kidneys (mainly in the 
glomeruli) and contribute to the development of glomerulonephritis, and that, 
in the later life of NZB mice, G antibody becomes detectable in the serum in 
free form only when its formation exceeds its neutralization by GSA. The finding 
that the activity of G antibody (per milligram 7S immunoglobulin) in the acid- 
buffer eluate of the kidneys of NZB mice with proteinuria was somewhat greater 
than that found in the serum supports this interpretation. MELLORS,  SHIRAI, AOKI, ttUEBNER,  AND  K-RAWCZYNSKI  129 
The observations were extended to the study of the pathogenesis of the ful- 
minating  renal  g]omerular  disease  (lupus  glomerulonephritis)  that  typifies 
(NZB  X  NZW) F1 hybrid mice (1, 4, 5). This renal glomerular disease is as- 
sociated with the development of positive LE cell test; (1, 4)  and anti-nuclear 
antibodies in high titer (5). DNA-anti-DNA immune complexes are implicated 
in the pathogenesis of the renal disease (22).  The present study revealed the 
presence  of murine leukemia virus  (MuLV)  CF  antigens in  extracts  of the 
spleen,  liver, and kidneys of (NZB X  NZW) FI hybrid mice, as well as NZW 
and NZB mice, as shown earlier for NZB mice (9).  C  type murine leukemia 
virus-like particles have also been found in the corresponding tissues of (NZB X 
NZW)  F1  hybrid mice  and  NZW  mice by  electron microscopic  study  (23; 
Mellors and Huang, unpublished work), as reported previously for NZB mice 
(21, 23-27). The present study further revealed that both GSA and G natural 
antibody were  detectable in  the  serum  of  (NZB  X  NZW)  F1  hybrid mice 
earlier than in NZB mice, and that the 50 % response time for GSA elimination 
and for proteinuria manifestation of renal glomerular disease occurred in the 
hybrid mice at 7.3-7.6 months of age.  In addition, murine leukemia virus IF 
antigens, together with host immunoglobulins, were demonstrated in the renal 
glomerular lesions of (NZB X  NZW) F1 hybrid mice, as shown previously for 
NZB mice by the immunofluorescence method (9) using a broadly reactive rat 
antiserum (20) with specificities for MuLV group- and viral and cellular G type- 
specific  antigens. The acid-buffer eluate of the kidneys of (NZB)<  NZW) F1 
mice has been prepared but not yet analyzed for GSA, G antibody, and anti- 
nuclear antibody. 
In the mouse system, the antibody against MuLV group-specific antigens 
has not yet been produced in any strains of mice. On the other hand, the anti- 
bodies against viral or cellular G type-specific antigens can be formed separately 
in different mouse strains. The G typing serum C57BL anti-AKR spontaneous 
leukemia K36  contains only the antibody reactive with cellular G  antigen(s) 
(8); the serum of some NZB mice contains the antibody against viral envelope 
G antigen(s) (8). Although as yet not proved it seems very likely that individual 
NZB mice may react immunologically with both viral and cellular G antigens. 
The illustrations of GSA in the acid-buffer eluate of the kidneys of NZB mice, 
as demonstrated by the immunofluorescence method (Fig. 2),  suggested that 
the NZB mouse serum reacted with either a broader range or a greater quantity 
of G  antigens, resulting in more intense and larger areas of positive staining 
than shown by the G  typing serum C57BL/6  anti-K36. Thus, in terms of G 
type specificities,  the serum of NZB mice may have a broad reactivity against 
G antigens similar to that of the rat antiserum against G antigens. 
The implication of murine leukemia and sarcoma viruses in the pathogenesis 
of glomerulonephritis in mice is supported by other observations. AKR mice 
are,  similar to NZB  mice,  congenitally and  persistently infected with  wild- 130  LEUKEMIA  AND  MICE GLOMERULONEPHRITIS  PATHOGENESIS 
type Gross leukemia virus; glomerulonephritis occurs in some AKR  mice in 
association with lymphatic leukemia (28). Mice experimentally infected with 
Rauscher,  Friend,  and  Passage  A  Gross  leukemia  viruses  (28,  29)  develop 
renal glomerular lesions. BALB/c mice neonatally infected with Molony leu- 
kemia and sarcoma viruses  (MLV and  MSV)  have MLV- or MSV-antibody 
complexes in the circulation and develop glomerular lesions,  with viral antigen 
and  antiviral antibody detectable in the kidneys (30). 
As  a  general phenomenon, wild-type murine leukemia virus  or virogene is 
virtually ubiquitous in mice (31). Its emerging role in the etiology and patho- 
genesis  of  spontaneous  murine  glomerulonephritis may be  more widespread 
than is presently recognized. 
NZB and (NZB X  NZW) F1 hybrid mice are a widely studied animal model 
of several human diseases of unknown etiology for which better understanding 
is  urgently  sought.  These  diseases  include  idiopathic  glomerulonephritis, 
systemic lupus erythematosus, and related connective tissue and autoimmune 
diseases.  In  the  association  of autoimmunity,  connective tissue  disease,  and 
lymphoid neoplasia  (2,  32,  33,  6),  NZB  mice provide a  uniquely challenging 
model of human diseases, because a similar constellation of disorders, or clinical 
transitions among them, are known to occur sometimes in man (34-37). 
SUMMARY 
The pathogenesis of the spontaneous  glomerulonephritis  of NZB  and (NZB  X 
NZW)  FI hybrid mice is related at least in part to the formation of natural anti- 
body against antigens of the G  (Gross) system, and apparently to the deposition 
in the glomeruli  of immune  complexes  of G  natural  antibody  with  G  soluble 
antigen  (GSA),  type-specific  antigen  specified  by  wild-t~)e  Gross  leukemia 
virus. G  natural antibody  and GSA  are detectable in the acid-buffer eluate of 
the kidneys of NZB  mice during the course of the glomerulonephritis.  (NZB  X 
NZW)  FI hybrid mice develop glomerulonephritis  and produce GSA  and free G 
natural antibody earlier in life  than do NZB  mice. The proteinuria manifestation 
of the gomerulonephritis  of (NZB  X  NZW)  FI hybrid mice becomes increasingly 
prevalent  as GSA  undergoes  immune  elimination  from  the circulation.  Gross 
leukemia  virus-specified  antigens  together  with  bound  immunoglobulins 
are located in the glomerular lesions of (NZB  X  NZW)  F1 hybrid mice, both in 
the mesangium  as observed in NZB  mice and also in the wall of the peripheral 
capillary loops of the glomeru]i. 
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